[¹⁴C]bis(2-chloroethoxy)methane: Comparative absorption, distribution, metabolism and excretion in rats and mice

References

• Bio/dynamics, Inc. A subchronic (3-month) oral toxicity study in the rat with formal [bis(2-chloroethoxy)methane]. East Millstone, NJUSA 1990; 22, Project No. 88-3429
   Google Scholar
• Burka LT, Sanders JM, Herr DW, Matthews HB. Metabolism of tris(2-chloroethyl) phosphate in rats and mice. Drug Metabolism and Disposition 1991; 19: 443–447
   PubMedGoogle Scholar
• Dubourg L, Michoudet C, Cochat P, Baverel G. Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide. Journal of the American Society of Nephrology 2001; 12: 1615–1623
   PubMed Web of Science ®Google Scholar
• Grunow W, Altmann H-J. Toxicokinetics of chloroethanol in the rat after single oral administration. Archives of Toxicology 1982; 49: 275–284
   PubMed Web of Science ®Google Scholar
• Haag WR, Mill T. Hydrolysis kinetics of bis(2-cloroethoxy)methane. Menlo Park, CAUSA 1989; 20, SRI Project No. 6877-1
   Google Scholar
• Hazardous Substances Data Bank (HSDB). National Library of Medicine TOXNET System. 1998, http://toxnet.nlm.nih.gov
   Google Scholar
• Hoffman U, Eichelbaum M, Seefried S, Meese CO. Identification of thiodiglycolic acid, thiodiglycolic acid sulfoxide, and (3-carboxymethylthio)lactic acid as major human biotransformation products of S-carboxymethyl-L-cysteine. Drug Metabolism and Disposition 1991; 19: 222–226
   PubMedGoogle Scholar
• Jean PA, Reed DJ. Utilization of glutathione during 1,2-dihaloethane metabolism in rat hepatocytes. Chemical Research in Toxicology 1992; 5: 386–391
   PubMedGoogle Scholar
• Joqueviel C, Malet-Martino M, Martino R. A 13C NMR study of 2-13C-chloroacetaldehyde, a metabolite of ifosfamide and cyclophosphamide, in the isolated perfused rabbit heart model. Initial observations on its cardiotoxicity and cardiac metabolism. Cellular and Molecular Biology 1997; 43: 773–782
   PubMedGoogle Scholar
• Lewis RJ. Hawley's condensed chemical dictionary. Van Nostrand Reinhold, New York 1993
   Google Scholar
• Matthews HB, Eustis SL, Haseman J. Toxicity and carcinogenicity of chronic exposure to tris(2-chloroethyl) phosphate. Fundamental and Applied Toxicology 1993; 20: 477–485
   PubMedGoogle Scholar
• Matthews HB, Dixon D, Herr DW, Tilson H. Subchronic toxicity studies indicate that tris(2-chloroethyl) phosphate administration results in lesions in the rat hippocampus. Toxicology and Industrial Health 1990; 6: 1–15
   PubMedGoogle Scholar
• Mathews JM, Etheridge AS, Raymer JH, Black SR, Pulliam DW, Jr, Burcher JR. Selective inhibition of cytochrome P450 2E1 in vivo and in vitro with trans-1,2-dichloroethylene. Chemical Research in Toxicology 1998; 11: 778–785
   PubMed Web of Science ®Google Scholar
• McFall JA, Antoine SR, DeLeon IR. Base-neutral extractable organic pollutants in biota and sediments from Lake Ponchartrain. Chemosphere 1985; 14: 1561–1569
   Google Scholar
• McKenna MC, Bieri JG. Multilayer cannula for long term infusion of unrestrained rats. Laboratory Animal Science 1984; 34: 308–310
   PubMedGoogle Scholar
• Moore MJ. Clinical pharmacokinetics of cyclophosphamide. Clinical Pharmacokinetics 1991; 20: 194–208
   PubMed Web of Science ®Google Scholar
• Shear NM, Schmidt CW, Huntley SL, Crawford DW, Finley BL. Evaluation of the factors relating combined sewer overflows with sediment contamination of the lower Passaic River. Marine Pollution Bulletin 1996; 32: 288–304
   Web of Science ®Google Scholar
• Sladek NE. Metabolism and pharmacokinetic behavior of cyclophosphamide and related oxazaphosphorines. Anticancer drugs: Reactive metabolism and drug interaction, G Powis. Pergamon Press, Oxford 1994
   Google Scholar
• Smyth HF, Carpenter CP. Further experience with the range finding test in the industrial toxicology laboratory. Journal of Industrial Hygiene and Toxicology 1948; 30: 63–64
   PubMedGoogle Scholar
• Sood C, O’Brian PJ. 2-Chloroacetaldhyde-induced cerebral glutathione depletion and neurtoxicity. British Journal of Cancer suppl. 1996; 27: S287–293
   PubMedGoogle Scholar
• Thomas BF, Martin BR. In vitro metabolism of (-)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl) cyclohexanol, a synthetic bicyclic cannabinoid analog. Drug Metabolism and Disposition 1990; 18: 1046–1054
   PubMed Web of Science ®Google Scholar
• Tilson HA, Veronesi B, McLamb RL, Matthews HB. Acute exposure to tris(2-chloroethyl)phosphate produces hippocampal neuronal loss and impairs learning in rats. Toxicology and Applied Pharmacology 1990; 106: 254–269
   PubMed Web of Science ®Google Scholar
• USEPA Office of Pollution. Prevention and Toxics (OPPT), High Production Volume Chemicals. March 6, 2007, http://www.epa.gov/oppt/iur/tools/data/2002-vol.htm
   Google Scholar
• Van Steenderen RA, Theron SJ, Hassett AJ. The occurrence of organic micropollutants in the Vaal River between Groontraai Dam and Parys. Water SA (Pretoria) 1987; 13: 209–214
   Web of Science ®Google Scholar
• Vietti D, Scherrer M. Polysulfides. Kirk-Othmer encyclopedia of chemical technology. 3rd ed, JI Kroschwitz. John Wiley & Sons, New York 1992; 19
   Google Scholar
• Visarius TM, Bähler H, Küpfer A, Cerny T, Lauterburg BH. Thiodiglycolic acid is excreted by humans receiving ifosfamide and inhibits mitochondrial function in rats. Drug Metabolism and Disposition 1998; 26: 193–196
   PubMed Web of Science ®Google Scholar
• Visarius TM, Stucki JW, Lauterburg BH. Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats. Journal of Pharmacology and Experimental Therapeutics 1999; 289: 820–824
   PubMed Web of Science ®Google Scholar
• Wagner T. Ifosfamide clinical pharmacokinetics. Clinical Pharmacokinetics 1994; 26: 439–456
   PubMed Web of Science ®Google Scholar
• Yllner S. Metabolism of chloroacetate-1-14C in the mouse. Acta Pharmacologica et Toxicologica 1971; 30: 69–80
   PubMedGoogle Scholar